Notably, ZEB2 and GFI1 have been found to be important for AML in several studies [70,71], but our approach has excluded both proteins as candidates, as they do not correlate with poor prognosis, at least when using the data from TCGA (Figure 1D). Here, GFI1 is linked to acute myeloid leukemia.